{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:49:25Z","timestamp":1783021765756,"version":"3.54.6"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017590","name":"Universit\u00e4tsklinikum Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Accurate determination of lymph-node (LN) metastases is a prerequisite for high precision radiotherapy. The primary aim is to characterise the performance of PET\/CT-based machine-learning classifiers to predict LN-involvement by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in stage-III NSCLC. Prediction models for LN-positivity based on [<jats:sup>18<\/jats:sup>F]FDG-PET\/CT features were built using logistic regression and machine-learning models random forest (RF) and multilayer perceptron neural network (MLP) for stage-III NSCLC before radiochemotherapy. A total of 675 LN-stations were sampled in 180 patients. The logistic and RF models identified SUV<jats:sub>max<\/jats:sub>, the short-axis LN-diameter and the echelon of the considered LN among the most important parameters for EBUS-positivity. Adjusting the sensitivity of machine-learning classifiers to that of the expert-rater of 94.5%, MLP (<jats:italic>P<\/jats:italic>\u2009=\u20090.0061) and RF models (<jats:italic>P<\/jats:italic>\u2009=\u20090.038) showed lower misclassification rates (MCR) than the standard-report, weighting false positives and false negatives equally. Increasing the sensitivity of classifiers from 94.5 to 99.3% resulted in increase of MCR from 13.3\/14.5 to 29.8\/34.2% for MLP\/RF, respectively. PET\/CT-based machine-learning classifiers can achieve a high sensitivity (94.5%) to detect EBUS-positive LNs at a low misclassification rate. As the specificity decreases rapidly above that level, a combined test of a PET\/CT-based MLP\/RF classifier and EBUS-TBNA is recommended for radiation target volume definition.<\/jats:p>","DOI":"10.1038\/s41598-022-21637-y","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T10:02:55Z","timestamp":1666260175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET\/CT"],"prefix":"10.1038","volume":"12","author":[{"given":"Maja","family":"Guberina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"P\u00f6ttgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nika","family":"Guberina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubertus","family":"Hautzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gauler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Ploenes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lale","family":"Umutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Wetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Theegarten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried E. E.","family":"Eberhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Metzenmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Wiesweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"Karpf-Wissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Santiago Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaid","family":"Darwiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stuschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"21637_CR1","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1056\/NEJMoa1910231","volume":"381","author":"MD Hellmann","year":"2019","unstructured":"Hellmann, M. D. et al. Nivolumab plus ipilimumab in advanced non-small-cell lung cancer. N. Engl. J. Med. 381, 2020 (2019).","journal-title":"N. Engl. J. Med."},{"key":"21637_CR2","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S1470-2045(19)30519-4","volume":"20","author":"R Hui","year":"2019","unstructured":"Hui, R. et al. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): A randomised, controlled, phase 3 study. Lancet Oncol. 20, 1670 (2019).","journal-title":"Lancet Oncol."},{"key":"21637_CR3","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","volume":"393","author":"DA Palma","year":"2019","unstructured":"Palma, D. A. et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial. Lancet 393, 2051\u20132058 (2019).","journal-title":"Lancet"},{"key":"21637_CR4","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1200\/JCO.19.01162","volume":"38","author":"JD Bradley","year":"2020","unstructured":"Bradley, J. D. et al. Long-term results of NRG oncology RTOG 0617: Standard- versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non-small-cell lung cancer. J. Clin. Oncol. 38, 706\u2013714 (2020).","journal-title":"J. Clin. Oncol."},{"key":"21637_CR5","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","volume":"379","author":"SJ Antonia","year":"2018","unstructured":"Antonia, S. J. et al. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. N. Engl. J. Med. 379, 2342\u20132350 (2018).","journal-title":"N. Engl. J. Med."},{"key":"21637_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2018.02.023","volume":"127","author":"U Nestle","year":"2018","unstructured":"Nestle, U. et al. ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer. Radiother. Oncol. 127, 1\u20135 (2018).","journal-title":"Radiother. Oncol."},{"key":"21637_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2017.06.003","volume":"124","author":"D De Ruysscher","year":"2017","unstructured":"De Ruysscher, D. et al. European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer. Radiother. Oncol. 124, 1\u201310 (2017).","journal-title":"Radiother. Oncol."},{"key":"21637_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1470-2045(20)30013-9","volume":"21","author":"U Nestle","year":"2020","unstructured":"Nestle, U. et al. Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): A multicentre, open-label, randomised, controlled trial. Lancet Oncol. 21, 581\u2013592 (2020).","journal-title":"Lancet Oncol."},{"key":"21637_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00066-021-01812-2","volume":"197","author":"C Lapa","year":"2021","unstructured":"Lapa, C. et al. Value of PET imaging for radiation therapy. Strahlenther. Onkol. 197, 1\u201323 (2021).","journal-title":"Strahlenther. Onkol."},{"key":"21637_CR10","doi-asserted-by":"publisher","first-page":"c1","DOI":"10.1055\/s-0034-1392453","volume":"47","author":"P Vilmann","year":"2015","unstructured":"Vilmann, P. et al. Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS). Endoscopy 47, c1 (2015).","journal-title":"Endoscopy"},{"key":"21637_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1378\/chest.13-1599","volume":"145","author":"DE Ost","year":"2019","unstructured":"Ost, D. E., Niu, J., Zhao, H., Grosu, H. & Giordano, S. H. Quality gaps and comparative effectiveness in lung cancer staging and diagnosis. Chest 145, 331 (2019).","journal-title":"Chest"},{"key":"21637_CR12","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1007\/s00259-021-05204-7","volume":"48","author":"M Guberina","year":"2021","unstructured":"Guberina, M. et al. Impact of EBUS-TBNA in addition to [(18)F]FDG-PET\/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC. Eur. J. Nucl. Med. Mol. Imaging 48, 2894 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"21637_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13014-021-01904-4","volume":"16","author":"M Guberina","year":"2021","unstructured":"Guberina, M. et al. Patterns of nodal spread in stage III NSCLC: Importance of EBUS-TBNA and (18)F-FDG PET\/CT for radiotherapy target volume definition. Radiat. Oncol. 16, 176 (2021).","journal-title":"Radiat. Oncol."},{"key":"21637_CR14","doi-asserted-by":"publisher","first-page":"e211S","DOI":"10.1378\/chest.12-2355","volume":"143","author":"GA Silvestri","year":"2013","unstructured":"Silvestri, G. A. et al. Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143, e211S-e250S (2013).","journal-title":"Chest"},{"key":"21637_CR15","unstructured":"SAS Release 9.4, SAS\/STAT 15.1 User's Guide (SAS Institute, Inc., 2018)."},{"key":"21637_CR16","unstructured":"SAS Institute Inc. SAS Enterprise Miner 14.3. https:\/\/documentation.sas.com\/doc\/de\/pgmsascdc\/9.4_3.2\/emhpprcref\/titlepage.htm (SAS Institute Inc., 2018). Accessed 5 october 2022."},{"key":"21637_CR17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.2517-6161.1974.tb00994.x","volume":"36","author":"M Stone","year":"1974","unstructured":"Stone, M. Cross-validatory choice and assessment of statistical predictions. J. R. Stat. Soc.: Ser. B (Methodol.) 36, 111\u2013133 (1974).","journal-title":"J. R. Stat. Soc.: Ser. B (Methodol.)"},{"key":"21637_CR18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.2517-6161.1974.tb00994.x","volume":"36","author":"M Stone","year":"1974","unstructured":"Stone, M. Cross-validatory choice and assessment of statistical predictions. J. R. Stat. Soc. Ser. B (Methodolol.) 36, 111\u201333 (1974).","journal-title":"J. R. Stat. Soc. Ser. B (Methodolol.)"},{"key":"21637_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2214\/ajr.184.1.01840014","volume":"184","author":"S Weinstein","year":"2005","unstructured":"Weinstein, S., Obuchowski, N. A. & Lieber, M. L. Clinical evaluation of diagnostic tests. Am. J. Roentgenol. 184, 14\u201319 (2005).","journal-title":"Am. J. Roentgenol."},{"key":"21637_CR20","first-page":"009519","volume":"2014","author":"M Schmidt-Hansen","year":"2014","unstructured":"Schmidt-Hansen, M. et al. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Cochrane Database Syst. Rev. 2014, 009519 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"21637_CR21","doi-asserted-by":"publisher","first-page":"879","DOI":"10.7326\/0003-4819-139-11-200311180-00013","volume":"139","author":"MK Gould","year":"2003","unstructured":"Gould, M. K. et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: A meta-analysis. Ann. Intern. Med. 139, 879\u2013892 (2003).","journal-title":"Ann. Intern. Med."},{"key":"21637_CR22","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.crad.2019.07.009","volume":"74","author":"DD Yang","year":"2019","unstructured":"Yang, D. D., Mirvis, E., Goldring, J., Patel, A. R. C. & Wagner, T. Improving diagnostic performance of (18)F-FDG-PET\/CT for assessment of regional nodal involvement in non-small cell lung cancer. Clin. Radiol. 74, e17\u2013e23 (2019).","journal-title":"Clin. Radiol."},{"key":"21637_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/resp.12409","volume":"20","author":"P Nguyen","year":"2015","unstructured":"Nguyen, P. et al. Comparison of objective criteria and expert visual interpretation to classify benign and malignant hilar and mediastinal nodes on 18-F FDG PET\/CT. Respirology (Carlton) 20, 129\u2013137 (2015).","journal-title":"Respirology (Carlton)"},{"key":"21637_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1183\/23120541.00103-2020","volume":"6","author":"JM Ramsahai","year":"2020","unstructured":"Ramsahai, J. M. et al. Does prior mediastinal lymph node aspiration contribute to false-positive positron emission tomography-computed tomography? ERJ Open Res. 6, 103 (2020).","journal-title":"ERJ Open Res."},{"key":"21637_CR25","doi-asserted-by":"publisher","first-page":"e78552","DOI":"10.1371\/journal.pone.0078552","volume":"8","author":"S Li","year":"2013","unstructured":"Li, S. et al. Implications of false negative and false positive diagnosis in lymph node staging of NSCLC by means of 18F-FDG PET\/CT. PLoS ONE 8, e78552 (2013).","journal-title":"PLoS ONE"},{"key":"21637_CR26","first-page":"1918","volume":"44","author":"H Vesselle","year":"2003","unstructured":"Vesselle, H., Turcotte, E., Wiens, L. & Haynor, D. Application of a neural network to improve nodal staging accuracy with 18F-FDG PET in non-small cell lung cancer. J. Nucl. Med. 44, 1918\u20131926 (2003).","journal-title":"J. Nucl. Med."},{"key":"21637_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13550-017-0260-9","volume":"7","author":"H Wang","year":"2017","unstructured":"Wang, H. et al. Comparison of machine learning methods for classifying mediastinal lymph node metastasis of non-small cell lung cancer from (18)F-FDG PET\/CT images. EJNMMI Res. 7, 11 (2017).","journal-title":"EJNMMI Res."},{"key":"21637_CR28","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1007\/s00330-020-07523-z","volume":"31","author":"J Yoo","year":"2021","unstructured":"Yoo, J. et al. Machine learning-based diagnostic method of pre-therapeutic (18)F-FDG PET\/CT for evaluating mediastinal lymph nodes in non-small cell lung cancer. Eur. Radiol. 31, 4184\u20134194 (2021).","journal-title":"Eur. Radiol."},{"key":"21637_CR29","doi-asserted-by":"crossref","unstructured":"Sibille, L. & Seifert, R. (18)F-FDG PET\/CT Uptake Classification in Lymphoma and Lung Cancer by Using Deep Convolutional Neural Networks, Vol. 294, 445\u2013452 (2020).","DOI":"10.1148\/radiol.2019191114"},{"key":"21637_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0001-2998(78)80014-2","volume":"8","author":"CE Metz","year":"1978","unstructured":"Metz, C. E. Basic principles of ROC analysis. Semin. Nucl. Med. 8, 283\u2013298 (1978).","journal-title":"Semin. Nucl. Med."},{"key":"21637_CR31","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/sim.3859","volume":"29","author":"DJ Hand","year":"2010","unstructured":"Hand, D. J. Evaluating diagnostic tests: The area under the ROC curve and the balance of errors. Stat. Med. 29, 1502\u20131510 (2010).","journal-title":"Stat. Med."},{"key":"21637_CR32","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1002\/sim.3937","volume":"29","author":"G R\u00fccker","year":"2010","unstructured":"R\u00fccker, G. & Schumacher, M. Summary ROC curve based on a weighted Youden index for selecting an optimal cutpoint in meta-analysis of diagnostic accuracy. Stat. Med. 29, 3069\u20133078 (2010).","journal-title":"Stat. Med."},{"key":"21637_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/LBR.0000000000000545","volume":"26","author":"TL Leong","year":"2019","unstructured":"Leong, T. L., Loveland, P. M., Gorelik, A., Irving, L. & Steinfort, D. P. Preoperative staging by EBUS in cN0\/N1 lung cancer: Systematic review and meta-analysis. J. Bronchol. Interv. Pulmonol. 26, 155\u2013165 (2019).","journal-title":"J. Bronchol. Interv. Pulmonol."},{"key":"21637_CR34","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1513\/AnnalsATS.201711-863OC","volume":"15","author":"H El-Osta","year":"2018","unstructured":"El-Osta, H., Jani, P., Mansour, A., Rascoe, P. & Jafri, S. Endobronchial ultrasound for nodal staging of patients with non-small-cell lung cancer with radiologically normal mediastinum. A meta-analysis. Ann. Am. Thorac. Soc. 15, 864\u2013874 (2018).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"21637_CR35","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S2213-2600(16)30317-4","volume":"4","author":"DA Korevaar","year":"2016","unstructured":"Korevaar, D. A. et al. Added value of combined endobronchial and oesophageal endosonography for mediastinal nodal staging in lung cancer: A systematic review and meta-analysis. Lancet Respir. Med. 4, 960\u2013968 (2016).","journal-title":"Lancet Respir. Med."},{"key":"21637_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/JTO.0b013e3181914357","volume":"4","author":"RC Rintoul","year":"2009","unstructured":"Rintoul, R. C. et al. EBUS-TBNA for the clarification of PET positive intra-thoracic lymph nodes\u2014An international multi-centre experience. J. Thorac. Oncol. 4, 44\u201348 (2009).","journal-title":"J. Thorac. Oncol."},{"key":"21637_CR37","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/thx.2008.109868","volume":"64","author":"K Adams","year":"2009","unstructured":"Adams, K., Shah, P. L., Edmonds, L. & Lim, E. Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer: Systematic review and meta-analysis. Thorax 64, 757\u2013762 (2009).","journal-title":"Thorax"},{"key":"21637_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/LBR.0000000000000372","volume":"24","author":"L Fuso","year":"2017","unstructured":"Fuso, L. et al. Influence of the learning effect on the diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes. J. Bronchol. Interv. Pulmonol. 24, 193\u2013199 (2017).","journal-title":"J. Bronchol. Interv. Pulmonol."},{"key":"21637_CR39","doi-asserted-by":"publisher","first-page":"1800800","DOI":"10.1183\/13993003.00800-2018","volume":"53","author":"LMM Crombag","year":"2019","unstructured":"Crombag, L. M. M. et al. Systematic and combined endosonographic staging of lung cancer (SCORE study). Eur. Respir. J. 53, 1800800 (2019).","journal-title":"Eur. Respir. J."},{"key":"21637_CR40","unstructured":"Proposed Regulatory Framework for Modifications to Artificial Intelligence\/Machine Learning (AI\/ML)-Based Software as a Medical Device (SaMD)\u2014Discussion Paper and Request for Feedback. https:\/\/www.fda.gov\/media\/122535\/download. (US Food and Drug Administration (FDA), 2019). Accessed 5 october 2022."},{"key":"21637_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jamainternmed.2018.7117","volume":"179","author":"F Wang","year":"2019","unstructured":"Wang, F., Casalino, L. P. & Khullar, D. Deep learning in medicine-promise, progress, and challenges. JAMA Intern. Med. 179, 293\u2013294 (2019).","journal-title":"JAMA Intern. Med."},{"key":"21637_CR42","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2017.18391","volume":"319","author":"AL Beam","year":"2018","unstructured":"Beam, A. L. & Kohane, I. S. Big data and machine learning in health care. JAMA 319, 1317\u20131318 (2018).","journal-title":"JAMA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21637-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21637-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21637-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T06:59:33Z","timestamp":1728197973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21637-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["21637"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-21637-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]},"assertion":[{"value":"17 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17511"}}